These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33844899)

  • 21. Paraoxonase-1 and oxidized lipoprotein lipids. The Cardiovascular Risk in Young Finns Study.
    Kresanov P; Vasankari T; Ahotupa M; Kaikkonen J; Hutri-Kähönen N; Juonala M; Kähönen M; Lehtimäki T; Viikari J; Raitakari OT
    Atherosclerosis; 2015 Aug; 241(2):502-6. PubMed ID: 26091975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Racial differences in paraoxonase-1 (PON1): a factor in the health of southerners?
    Davis KA; Crow JA; Chambers HW; Meek EC; Chambers JE
    Environ Health Perspect; 2009 Aug; 117(8):1226-31. PubMed ID: 19672401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PON-1 haplotype (-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients.
    Zaragoza-García O; Guzmán-Guzmán IP; Moreno-Godínez ME; Navarro-Zarza JE; Antonio-Vejar V; Ramírez M; Parra-Rojas I
    Clin Rheumatol; 2021 Feb; 40(2):741-752. PubMed ID: 32556934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PON1 lactonase activity and its association with cardiovascular disease.
    Murillo-González FE; Ponce-Ruiz N; Rojas-García AE; Rothenberg SJ; Bernal-Hernández YY; Cerda-Flores RM; Mackness M; Barrón-Vivanco BS; González-Arias CA; Ponce-Gallegos J; Medina-Díaz IM
    Clin Chim Acta; 2020 Jan; 500():47-53. PubMed ID: 31626760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arylesterase activity and antioxidant status depend on PON1-Q192R and PON1-L55M polymorphisms in subjects with increased risk of cardiovascular disease consuming walnut-enriched meat.
    Nus M; Frances F; Librelotto J; Canales A; Corella D; Sánchez-Montero JM; Sánchez-Muniz FJ
    J Nutr; 2007 Jul; 137(7):1783-8. PubMed ID: 17585031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypes and concentration of PON1 in cardiovascular disease: The role of nutrient intake.
    Ponce-Ruiz N; Murillo-González FE; Rojas-García AE; Bernal Hernández YY; Mackness M; Ponce-Gallegos J; Barrón-Vivanco BS; Hernández-Ochoa I; González-Arias CA; Ortega Cervantes L; Cardoso-Saldaña G; Medina-Díaz IM
    Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):40-48. PubMed ID: 31757567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paraoxonase 1 gene polymorphisms and enzyme activities in coronary artery disease and its relationship to serum lipids and glycemia.
    Fridman O; Gariglio L; Riviere S; Porcile R; Fuchs A; Potenzoni M
    Arch Cardiol Mex; 2016; 86(4):350-357. PubMed ID: 27640339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between promoter polymorphism (-108C>T) of paraoxonase1 gene and it
    Shakeri R; Khajeniazi S; Marjani A
    Clin Chim Acta; 2017 Nov; 474():34-37. PubMed ID: 28866115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity.
    Bortolasci CC; Vargas HO; Souza-Nogueira A; Gastaldello Moreira E; Vargas Nunes SO; Berk M; Dodd S; Barbosa DS; Maes M
    Redox Rep; 2014 Nov; 19(6):232-41. PubMed ID: 25037113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis.
    Mucientes A; Fernández-Gutiérrez B; Herranz E; Rodriguez-Rodriguez L; Varadé J; Urcelay E; Lamas JR
    Clin Rheumatol; 2019 May; 38(5):1329-1337. PubMed ID: 30588556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylmercury exposure, PON1 gene variants and serum paraoxonase activity in Eastern James Bay Cree adults.
    Drescher O; Dewailly E; Diorio C; Ouellet N; Sidi EA; Abdous B; Valera B; Ayotte P
    J Expo Sci Environ Epidemiol; 2014 Nov; 24(6):608-14. PubMed ID: 24448003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low protective PON1 lactonase activity in an Arab population with high rates of coronary heart disease and diabetes.
    Gugliucci A; Caccavello R; Nassar H; Abu Ahmad W; Sinnreich R; Kark JD
    Clin Chim Acta; 2015 May; 445():41-7. PubMed ID: 25801214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of lead, cadmium and mercury with paraoxonase 1 activity and malondialdehyde in a general population in Southern Brazil.
    Almeida Lopes ACB; Urbano MR; Souza-Nogueira A; Oliveira-Paula GH; Michelin AP; Carvalho MFH; Camargo AEI; Peixe TS; Cabrera MAS; Paoliello MMB
    Environ Res; 2017 Jul; 156():674-682. PubMed ID: 28477577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paraoxonase 1 response to a high-fat diet: gender differences in the factors involved.
    Thomàs-Moyà E; Gianotti M; Proenza AM; Lladó I
    Mol Med; 2007; 13(3-4):203-9. PubMed ID: 17592556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Human Paraoxonase-1 Polymorphism (Q192R) on Serum Levels of Clinical Biomarkers Indicatives of Cardiovascular Diseases Risk in Mexican Women.
    Ochoa-Martínez ÁC; Orta-García ST; Varela-Silva JA; Pérez-Maldonado IN
    Biochem Genet; 2020 Oct; 58(5):801-820. PubMed ID: 32519276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary modifications and gene polymorphisms alter serum paraoxonase activity in healthy women.
    Rantala M; Silaste ML; Tuominen A; Kaikkonen J; Salonen JT; Alfthan G; Aro A; Kesäniemi YA
    J Nutr; 2002 Oct; 132(10):3012-7. PubMed ID: 12368388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paraoxonase 192 polymorphism and its relationship to serum lipids in Turkish renal transplant recipients.
    Agachan B; Yilmaz H; Isbir T; Akoglu E
    Transplant Proc; 2004 Jun; 36(5):1385-6. PubMed ID: 15251338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Replacement of saturated with unsaturated fats had no impact on vascular function but beneficial effects on lipid biomarkers, E-selectin, and blood pressure: results from the randomized, controlled Dietary Intervention and VAScular function (DIVAS) study.
    Vafeiadou K; Weech M; Altowaijri H; Todd S; Yaqoob P; Jackson KG; Lovegrove JA
    Am J Clin Nutr; 2015 Jul; 102(1):40-8. PubMed ID: 26016869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population.
    Bounafaa A; Berrougui H; Ghalim N; Nasser B; Bagri A; Moujahid A; Ikhlef S; Camponova P; Yamoul N; Simo OK; Essamadi A; Khalil A
    PLoS One; 2015; 10(8):e0133719. PubMed ID: 26241956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population.
    Schwedhelm C; Nimptsch K; Bub A; Pischon T; Linseisen J
    Br J Nutr; 2016 Feb; 115(4):730-6. PubMed ID: 26769660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.